Generate a tailored SOP for Dr. Verena Schultz. Improve your application with a focused, well-structured draft.
Research Associate Verena Schultz is fascinated by the intersection of biochemistry and biology within the nervous system, particularly in the context of Multiple Sclerosis and Zika Virus. She began her journey at Tübingen University, focusing on protein modifications related to Multiple Sclerosis. Continuing her studies at Göttingen University, she gained extensive knowledge of the neuropathology associated with Multiple Sclerosis, particularly the interplay between early remyelination and axonal damage during her PhD. Verena broadened her knowledge in immunology at the University of Glasgow, investigating the role of Type I Interferon responses during viral infections of the central nervous system. Her current research aims to delve further into the biology of Zika virus infection within the nervous system. Verena's work has highlighted the complexity of early remyelination and its protective effects on axons, suggesting that timely remyelination is vital for recovery following demyelinating events. With significant insights into the pathogenicity of Zika virus, her research contributes to understanding its impact on neurological health, paving the way for future studies focused on the mechanisms of Zika virus-related central nervous system injuries.
University of Glasgow • Glasgow, Scotland
Conducting research in the field of virology, focusing on the interactions of Zika virus and the central nervous system.